Collegium Pharmaceutical, Inc. (COLL) Operating margin 2016–2025
Collegium Pharmaceutical, Inc. (COLL) operating margin by fiscal year — reported operating income divided by reported revenue.
23.0%FY2025 · since FY2016: -5498.7% → 23.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 23.0% | -3.9 pp |
| FY2024 | 26.9% | -2.6 pp |
| FY2023 | 29.5% | +22.3 pp |
| FY2022 | 7.2% | +0.8 pp |
| FY2021 | 6.4% | -11.8 pp |
| FY2020 | 18.1% | +26.1 pp |
| FY2019 | -8.0% | -0.6 pp |
| FY2018 | -7.4% | +257.6 pp |
| FY2017 | -264.9% | +5233.7 pp |
| FY2016 | -5498.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice